These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11729638)

  • 1. [Inhibitors of absorption as anti-obesity drugs].
    Tsuji M; Saito N; Inoue S
    Nihon Yakurigaku Zasshi; 2001 Nov; 118(5):340-6. PubMed ID: 11729638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of orlistat in the treatment of obesity].
    Paragh G; Bajnok L
    Orv Hetil; 2005 Mar; 146(11):493-8. PubMed ID: 15813187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orlistat inhibits dietary cholesterol absorption.
    Mittendorfer B; Ostlund RE; Patterson BW; Klein S
    Obes Res; 2001 Oct; 9(10):599-604. PubMed ID: 11595776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia.
    Micić D; Ivković-Lazar T; Dragojević R; Jorga J; Stokić E; Hajduković Z
    Med Pregl; 1999; 52(9-10):323-33. PubMed ID: 10624380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orlistat--a novel weight loss therapy.
    Lucas KH; Kaplan-Machlis B
    Ann Pharmacother; 2001 Mar; 35(3):314-28. PubMed ID: 11261530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orlistat: a review of its use in the management of obesity.
    Hvizdos KM; Markham A
    Drugs; 1999 Oct; 58(4):743-60. PubMed ID: 10551441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome.
    Svendsen M; Helgeland M; Tonstad S
    J Hum Nutr Diet; 2009 Feb; 22(1):55-63. PubMed ID: 19192027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orlistat.
    Wong NN; Cheng-Lai A
    Heart Dis; 2000; 2(2):174-81. PubMed ID: 11728255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orlistat: its current status as an anti-obesity drug.
    Ballinger A; Peikin SR
    Eur J Pharmacol; 2002 Apr; 440(2-3):109-17. PubMed ID: 12007529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orlistat for obesity.
    Med Lett Drugs Ther; 1999 Jun; 41(1055):55-6. PubMed ID: 10436767
    [No Abstract]   [Full Text] [Related]  

  • 12. [Orlistat (Xenical)].
    Crenier L; Sternon J
    Rev Med Brux; 1999 Jun; 20(3):159-63. PubMed ID: 10429540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
    Chanoine JP; Hampl S; Jensen C; Boldrin M; Hauptman J
    JAMA; 2005 Jun; 293(23):2873-83. PubMed ID: 15956632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug strategies for the treatment of obesity.
    Alemany M; Remesar X; Fernández-López JA
    IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive gastrointestinal effects with concomitant use of olestra and orlistat.
    Heck AM; Calis KA; McDuffie JR; Carobene SE; Yanovski JA
    Ann Pharmacother; 2002 Jun; 36(6):1003-5. PubMed ID: 12022901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of obesity: an update.
    Schurgin S; Siegel RD
    Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyphenolic Compounds as Pancreatic Lipase Inhibitors.
    Buchholz T; Melzig MF
    Planta Med; 2015 Jul; 81(10):771-83. PubMed ID: 26132857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in the pharmacological management of obesity.
    Carek PJ; Dickerson LM
    Drugs; 1999 Jun; 57(6):883-904. PubMed ID: 10400403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: malnutrition and maltreatment--a comment on orlistat for the treatment of obesity.
    Cahill A; Lean ME
    Aliment Pharmacol Ther; 1999 Aug; 13(8):997-1002. PubMed ID: 10468673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boerhaavia diffusa inhibits key enzymes linked to type 2 diabetes in vitro and in silico; and modulates abdominal glucose absorption and muscle glucose uptake ex vivo.
    Oyebode OA; Erukainure OL; Chukwuma CI; Ibeji CU; Koorbanally NA; Islam S
    Biomed Pharmacother; 2018 Oct; 106():1116-1125. PubMed ID: 30119178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.